KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) EBT (2016 - 2025)

Historic EBT for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $83.5 million.

  • Chemed's EBT fell 1730.69% to $83.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $370.5 million, marking a year-over-year decrease of 619.82%. This contributed to the annual value of $399.5 million for FY2024, which is 1401.33% up from last year.
  • As of Q3 2025, Chemed's EBT stood at $83.5 million, which was down 1730.69% from $71.1 million recorded in Q2 2025.
  • Chemed's EBT's 5-year high stood at $120.1 million during Q4 2024, with a 5-year trough of $70.3 million in Q2 2023.
  • In the last 5 years, Chemed's EBT had a median value of $84.7 million in 2022 and averaged $88.4 million.
  • Per our database at Business Quant, Chemed's EBT plummeted by 3408.78% in 2021 and then soared by 4028.28% in 2023.
  • Quarter analysis of 5 years shows Chemed's EBT stood at $96.1 million in 2021, then decreased by 14.28% to $82.4 million in 2022, then skyrocketed by 40.28% to $115.6 million in 2023, then rose by 3.92% to $120.1 million in 2024, then crashed by 30.45% to $83.5 million in 2025.
  • Its last three reported values are $83.5 million in Q3 2025, $71.1 million for Q2 2025, and $95.7 million during Q1 2025.